Arsenic trioxide with ascorbic acid and high-dose melphalan: A new preparative regimen for autologous hematopoietic stem cell transplantation for multiple myeloma.

被引：0
|
作者：
Qazilbash, MH [1 ]
Davis, MS [1 ]
Ana, A [1 ]
Roden, L [1 ]
Libunao, F [1 ]
Tball, PF [1 ]
Wang, XM [1 ]
Couriel, D [1 ]
De Lima, M [1 ]
Hosing, C [1 ]
Kebriaei, P [1 ]
Weber, D [1 ]
Wang, M [1 ]
Jones, RB [1 ]
Matthes, SG [1 ]
Champlin, RE [1 ]
Giralt, SA [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1159
引用
收藏
页码：338A / 339A
页数：2
相关论文
共 50 条
  • [21] High-dose idarubicine, busulphan and melphalan as conditioning for autologous blood stem cell transplantation in multiple myeloma. A feasibility study
    Meloni, G
    Capria, S
    Trasarti, S
    Ferrazza, G
    Micozzi, A
    Petrucci, MT
    Simone, F
    Trisolini, SM
    Mandelli, F
    BONE MARROW TRANSPLANTATION, 2000, 26 (10) : 1045 - 1049
  • [22] High-dose idarubicine, busulphan and melphalan as conditioning for autologous blood stem cell transplantation in multiple myeloma. A feasibility study
    G Meloni
    S Capria
    S Trasarti
    G Ferrazza
    A Micozzi
    MT Petrucci
    F Simone
    SM Trisolini
    F Mandelli
    Bone Marrow Transplantation, 2000, 26 : 1045 - 1049
  • [23] Microbiota dysbiosis after high-dose melphalan and autologous hematopoietic cell transplantation in multiple myeloma
    Malard, Florent
    Battipaglia, Giorgia
    Gaugler, Beatrice
    Siblany, Lama
    van de Wyngaert, Zoe
    Bonnin, Agnes
    Dulery, Remy
    Banet, Anne
    Stocker, Nicolas
    Ricard, Laure
    Brissot, Eolia
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2023, 58 (11) : 1275 - 1278
  • [24] Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma
    Miyamoto, Toshihiro
    Yoshimoto, Goichi
    Kamimura, Tomohiko
    Muta, Tsuyoshi
    Takashima, Shuichiro
    Ito, Yoshikiyo
    Shiratsuchi, Motoaki
    Choi, Ilseung
    Kato, Koji
    Takenaka, Katsuto
    Iwasaki, Hiromi
    Takamatsu, Yasushi
    Teshima, Takanori
    Akashi, Koichi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (03) : 337 - 345
  • [25] Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma
    Toshihiro Miyamoto
    Goichi Yoshimoto
    Tomohiko Kamimura
    Tsuyoshi Muta
    Shuichiro Takashima
    Yoshikiyo Ito
    Motoaki Shiratsuchi
    Ilseung Choi
    Koji Kato
    Katsuto Takenaka
    Hiromi Iwasaki
    Yasushi Takamatsu
    Takanori Teshima
    Koichi Akashi
    International Journal of Hematology, 2013, 98 : 337 - 345
  • [26] High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma
    D Sivaraj
    W Bacon
    G D Long
    D A Rizzieri
    M E Horwitz
    K M Sullivan
    Y Kang
    Z Li
    N J Chao
    C Gasparetto
    Bone Marrow Transplantation, 2018, 53 : 34 - 38
  • [27] Microbiota dysbiosis after high-dose melphalan and autologous hematopoietic cell transplantation in multiple myeloma
    Florent Malard
    Giorgia Battipaglia
    Béatrice Gaugler
    Lama Siblany
    Zoe van de Wyngaert
    Agnes Bonnin
    Rémy Duléry
    Anne Banet
    Nicolas Stocker
    Laure Ricard
    Eolia Brissot
    Mohamad Mohty
    Bone Marrow Transplantation, 2023, 58 : 1275 - 1278
  • [28] High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma
    Sivaraj, D.
    Bacon, W.
    Long, G. D.
    Rizzieri, D. A.
    Horwitz, M. E.
    Sullivan, K. M.
    Kang, Y.
    Li, Z.
    Chao, N. J.
    Gasparetto, C.
    BONE MARROW TRANSPLANTATION, 2018, 53 (01) : 34 - 38
  • [29] BUSULFAN AND CYCLOPHOSPHAMIDE HAS SIMILAR OUTCOMES TO HIGH DOSE MELPHALAN AS A PREPARATIVE REGIMEN FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA
    Mahindra, A.
    Bolwell, B.
    Rybicki, L.
    Dean, R.
    Poblman, B.
    Sobecks, R.
    Andresen, S.
    Sweetenbam, J.
    Kalaycio, M.
    Copelan, E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 69 - 69
  • [30] Comparison of conditioning regimen toxicities among autologous stem cell transplantation eligible multiple myeloma patients: High-dose melphalan versus high-dose melphalan and bortezomib
    Aypar, Eda
    Izzettin, Fikret Vehbi
    Aki, Sahika Zeynep
    Sancar, Mesut
    Yegin, Zeynep Arzu
    Turkoz-Sucak, Gulsan
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (04) : 281 - 289
12345